We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · August 05, 2021

SCD Is Associated With Increased Risk of Severe COVID-19 Outcomes

Annals of Internal Medicine


Additional Info

Annals of Internal Medicine
Sickle Cell Disorders and Severe COVID-19 Outcomes: A Cohort Study
Ann. Intern. Med 2021 Jul 20;[EPub Ahead of Print], AK Clift, D Saatci, CAC Coupland, H Dambha-Miller, J Hippisley-Cox

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading